AIM IMMUNOTECH INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $37.00K.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-12-31 was $0.00.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-09-30 was $0.00.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was -$1.00K.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was -$46.00K, a 103.12% decline from fiscal 2019.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.47M, a 1674.70% increase from fiscal 2018.
- AIM IMMUNOTECH INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $83.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | -$46.00K 10-K · filed 2022-03-31 | |
| 2020-06-30 | $37.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2020-03-30 | $1.47M 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-31 | |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $83.00K 10-K · filed 2020-03-30 |
| 2017-09-30 | $641.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | |
| 2017-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | |
| 2017-03-31 | $67.00K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |